×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

ASCO 2019

Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, where oncology professionals, patients and advocates from around the world gather to share the latest advances in the field.
Lowell Hart
With new ways to treat chemotherapy-induced side effects, it seems that chemotherapy, combined with checkpoint inhibitors, is here to stay for the foreseeable future, according to one expert.
Jessica Skarzynski
With a wealth of drugs available for the treatment of liver cancer, one expert explained how combination therapy may be where the future is headed.
R. Donald Harvey
One expert weighs the benefits and drawbacks of expanding clinical trials to be more inclusive and reflective of the general patient population with cancer.
Sara Karlovitch
A breast cancer survivor and hereditary cancer expert discussed how patients can find accurate information about genetic mutations.
Katie Kosko
A medical oncologist discusses the findings of three clinical trials presented during the 2019 American Society of Clinical Oncology Annual Meeting.
Jessica Skarzynski
One expert discusses the “extremely interesting and extremely dynamic” field of renal cell carcinoma, and how recent research and FDA actions could offer hope for patients and their doctors.
Kristie L. Kahl
While half of women with gynecologic cancer reported experiencing significant fatigue during treatment, only 8% of survivors had symptoms regress without intervention.
Kristie L. Kahl
Long-term survivors of pediatric neuroblastoma may be at an increased risk for neurocognitive impairment – in particular, due to age at diagnosis and the type of treatment received.
Kristie L. Kahl
A glioblastoma (GBM)-specific app, called OurBrainBank, efficiently collected patients’ symptoms – offering many hope for future research, according to founder Jessica Morris.
Jennifer King
Studies show that the social stigma can actually affect a patient’s level of care and lead to worse health outcomes.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other